|
KMID : 0380020030180040335
|
|
Korean Journal of Biotechnology and Bioengineering
2003 Volume.18 No. 4 p.335 ~ p.339
|
|
|
Effect and Safety of Replacement Therapy with Insumon in Tyne 2 Diabetes Mellitus
|
|
Hong Uk-Ki
Kim Jae-Soo
Park Jun-Hong
Park Se-Jung
Jang Hak-Cheol
Han In-Kwon
|
|
|
Abstract
|
|
|
|
This research was concentrated to Investigate the effects of Insumon as a newly developed dietary supplement in patients with type 2 diabetes. The average glycated hemoglobin level was dropped from 7.01.1％ to 6.70.9％ after 8 weeks with statistic significance (p＝0.0202). For patients of HbA1c over 7％, the average HbA1c significantly decreased from 8.10.8％ to 7.50.8％ (p＝0.0171). The average fasting blood glucose level was decreased significantly from 9.51.2 mmol/L (171.622.3 mg/dL) to 8.51.5 mmol/L (152.326.3 mg/dL) (p=0.0262) after 4 weeks and to 8.81.5 mmol/L (158.324.1 mg/dL) (p=0.0445) after 8 weeks in the group of patients of FBG of over 7.8 mmol/L (140 mg/dL). The average HDL cholesterol level was increased significantly after 8 weeks from 1.20.2 mmol/L (46.58.6 mg/dL) to 1.30.3 mmol/L (51.610.9 mg/dL) (p=0.0007). Thus, these results suggested that patients with type 2 diabetes might benefit by Insumon as a herbal dietary supplement without any serious side effects.
|
|
|
KEYWORD
|
|
|
Insumon, HbA1c, FBG, herbal supplement
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|